- PAROLA TRIAL. PARa-aOrtic LymphAdenectomy in locally advanced cervical cancer (PAROLA trial): a GINECO, ENGOT, and GCIG study. International multicenter, randomized, phase III study. Eligible patients will be randomized 1:1 between PET/CT staging followed by chemoradiation (control arm), or surgical staging followed by tailored chemo-radiation (experimental arm). Randomization will be stratified by tumor stage according to TNM classification, center, and adjuvant treatment
Contatti:
Dott. Alberto Daniele daniele.al@ospedale.cuneo.it
Dott.ssa Marinella Destefanis destefanis.m@ospedale.cuneo.it
Dott.ssa Marcella Occelli occelli.m@ospedale.cuneo.it
Dott.ssa Elena Olearo olearo.e@ospedale.cuneo.it
Dott.ssa Lorenza Palmero palmero.l@ospedale.cuneo.it
Dott.ssa Silvia Violante violante.s@ospedale.cuneo.it